Riley Researcher Recognized as Extraordinary Leader in Diabetes Research
Carmella Evans-Molina, MD, PhD, is the recipient of the 2023 Outstanding Scientific Achievement Award from the American Diabetes Association (ADA). This award recognizes diabetes research that demonstrates originality and particular independence of thought. Dr. Evans-Molina’s work is focused on understanding how pathways in the β-cell contribute to type 1 diabetes development, and the development of new biomarkers that can accurately predict type 1 diabetes risk. She is recognized as a leader in the field.
Dr. Evans-Molina serves as Director of the IU Center for Diabetes and Metabolic Diseases and as the Program Leader for the Wells Diabetes Research Program. The generosity of Riley Children’s Foundation donors supports research efforts and initiatives within the research program. “Support from donors allows our group to pursue high-risk and potentially high reward ideas, and build evidence for continued grant support and future proposals. We are incredibly grateful,” Dr. Evans-Molina shared.
In 2022, Dr. Evans-Molina was named President of the Immunology of Diabetes Society (IDS), a scientific society dedicated to improving understanding and treatment of type 1 diabetes. IDS organizes a Congress every 18 months in major centers in Europe, North America, and Asia, where there are scientific presentations to further this goal.
Award recipients will be honored at a ceremony at the ADA’s 83rd Scientific Sessions in San Diego this June. Congratulations, Dr. Evans-Molina!